Skip to content

Sixth Street Specialty Lending TSLX Net realized gains (losses)

Net realized gains (losses) at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$28K+1,300%
Clearwater Analytics logo
Clearwater AnalyticsCWAN
$0-100%
Voya Financial logo
Voya FinancialVOYA
-$45M-38.5%
Cytokinetics logo
CytokineticsCYTK
$61K
Sixth Street Specialty Lending logo
Sixth Street Specialty LendingTSLX
-$39.26M-3,621%
Old Republic International logo
Old Republic InternationalORI
$85.3M+128%

Other financials

Income statement

See full
Net income-$26.0M-170%
EPS (diluted)-$0.27-169%

Balance sheet

See full
Cash & equivalents$29.2M-38.3%
Total debt$1.8B-2.2%
Total assets$3.4B-3.0%

Cash flow

See full
Operating cash flow-$23.4M-116%

Valuation

See full
Market cap$1.57B-17.0%
Enterprise value$3.34B-9.7%
P/E14.6×+3.8×

Where this comes from

Reported directly by Sixth Street Specialty Lending in its filing.

Tagged under the XBRL concept us-gaap:RealizedInvestmentGainsLosses.

The official record: Sixth Street Specialty Lending’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sixth Street Specialty Lending's net realized gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sixth Street Specialty Lending's net realized gains (losses)?
Sixth Street Specialty Lending (TSLX) reported net realized gains (losses) of -$39.26M in Q1 2026.
How has Sixth Street Specialty Lending's net realized gains (losses) changed year-over-year?
Sixth Street Specialty Lending's net realized gains (losses) decreased by 3620.8% year-over-year, from $1.12M to -$39.26M.
What is the long-term trend for Sixth Street Specialty Lending's net realized gains (losses)?
Over 3 years (2022 to 2025), Sixth Street Specialty Lending's net realized gains (losses) has grown at a 48.4% compound annual growth rate (CAGR), from $14.74M to -$48.18M.
What does net realized gains (losses) mean?
Reflects the actual gains or losses recognized upon the sale, redemption, or exit of investment assets. Unlike unrealized gains, this represents cash-equivalent outcomes from completed investment cycles. It serves as a primary measure of the company's ability to successfully execute its investment strategy and generate profitable exits.